Clinical Trial Update: Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.

View source ↗

Summary

This clinical trial update notes that the study assessing CMV infection risk in renal transplant recipients using the QuantiFERON-CMV test has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: University Hospital, Limoges | Conditions: Renal Transplant Recipient, Immunized Against the Cytomegalovirus | Status: TERMINATED